With weight loss injectables like Ozempic and Mounjaro taking the world by storm, the diet industry is seemingly being left ...

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...

Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited ...

The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.

Weight loss can be a challenging journey, especially when seeking effective and accessible solutions. The rise in popularity ...

The American Stroke Association has released new guidelines to lower your risk of stroke. Here’s what the organization ...

GLP-1 drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...

Novo has fired the most recent shot, asking the U.S. regulator to prevent compounders from manufacturing copycat versions of ...

Earlier this month, WeightWatchers made the extraordinary announcement that it would be offering its own version of the 'fat ...

On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral GLP-1R agonist, Rybelsus, ...

The supplements have the potential to reduce hunger and appetite, as well as lower blood pressure, reduce joint inflammation ...